Q1 Earnings Estimate for TG Therapeutics Issued By B. Riley
TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) – Analysts at B. Riley issued their Q1 2025 earnings estimates for shares of TG Therapeutics in a research note issued to investors on Tuesday, March 4th. B. Riley analyst M. Mamtani forecasts that the biopharmaceutical company will post earnings of $0.21 per share for the quarter. The […]
